Today, the Food and Drug Administration (FDA) announced its approval of pretomanid, a new drug developed to treat Extensively Drug-Resistant Tuberculosis (XDR-TB) and treatment intolerant/non-responsive Multidrug-Resistant (MDR) TB.
The annual U.S. News & World Report's Best Hospitals rankings were released Tuesday.
Study Finds Climate Change, Rising Carbon Dioxide Levels Could Reduce Global Availability of Key Nutrients
A new study has found that over the next 30 years, climate change and increasing carbon dioxide (CO2) could significantly reduce the availability of critical nutrients like protein, iron and zinc.
A new study models the impact of increased treatment of hepatitis C virus (HCV) infection among people who inject drugs.
A new study finds that the percentage of Medicare plans that required prior authorization for the most commonly prescribed medication to treat opioid addiction have decreased dramatically.
U.S. News & World Report today released the 2019-20 Best Children's Hospitals rankings of America's top pediatric facilities.
Researchers to Address Effects of the Global Opioid Epidemic on Women and Families, as Well as Marijuana Use Among Teens
SAN ANTONIO, Texas — Women and their families and the devastating effects of the global opioid epidemic, along with the increasing use of marijuana by teenagers, are the focus of leading public health researchers and other experts this week at the 11th International Women’s and Children’s Health...
A study of the economic benefits of Global Positioning System (GPS) shows 10 key industries generated $1.4 trillion since GPS was made available for private-sector use.
New Study Suggests Majority of Social Media Accounts Following JUUL E-Cigarette Company on Twitter Belong to Underage Youth
RESEARCH TRIANGLE PARK, N.C. — A study of the Twitter account of JUUL e-cigarette products estimates that 80.6 percent of its followers are 13 to 20 years old with 44.9 percent of those followers only 13-17 years old, well under the legal age of 21 to purchase tobacco products in large parts of...
New Study Finds Patients on High Doses of Opioid Medication Are Being Rapidly Discontinued, Leading to Greater Risk of Emergency Department Visits and Hospitalizations
A new study from RTI International, a nonprofit research institute, finds that patients taking high doses of opioid pain medications often suddenly discontinue their medication, placing them at greater risk of an opioid-related adverse event like an emergency room visit or hospitalization.